Extended Data Fig. 9: Safety assessment of TLC-2716 in humans.
Overall summary of treatment-emergent adverse events (TEAEs) in Phase 1 study of TLC-2716 in 50 healthy subjects involved in the MAD cohort.
Extended Data Fig. 9: Safety assessment of TLC-2716 in humans. | Nature Medicine
